Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan versus continuous positive airway pressure for cardiovascular complications in sleep apnea
2007-005333-11Phase 2Active
- Sponsor
- CHU Grenoble Alpes
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of bosentan in sleep apnea and hypertension (HTN) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: 24-hour ambulatory mean diastolic blood pressure. Started Oct 2007; status: active.
02
Drugs
bosentan
03
Conditions
sleep apneahypertension (HTN)
Beyond the preview
Go deeper on 2007-005333-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005333-11.